Welch v. Bio-Reference Laboratories, Inc.

CourtCourt of Appeals for the Second Circuit
DecidedFebruary 14, 2023
Docket21-1447
StatusUnpublished

This text of Welch v. Bio-Reference Laboratories, Inc. (Welch v. Bio-Reference Laboratories, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Second Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Welch v. Bio-Reference Laboratories, Inc., (2d Cir. 2023).

Opinion

21-1447-cv Welch v. Bio-Reference Laboratories, Inc.

UNITED STATES COURT OF APPEALS FOR THE SECOND CIRCUIT

SUMMARY ORDER

RULINGS BY SUMMARY ORDER DO NOT HAVE PRECEDENTIAL EFFECT. CITATION TO A SUMMARY ORDER FILED ON OR AFTER JANUARY 1, 2007, IS PERMITTED AND IS GOVERNED BY FEDERAL RULE OF APPELLATE PROCEDURE 32.1 AND THIS COURT’S LOCAL RULE 32.1.1. WHEN CITING A SUMMARY ORDER IN A DOCUMENT FILED WITH THIS COURT, A PARTY MUST CITE EITHER THE FEDERAL APPENDIX OR AN ELECTRONIC DATABASE (WITH THE NOTATION “SUMMARY ORDER”). A PARTY CITING A SUMMARY ORDER MUST SERVE A COPY OF IT ON ANY PARTY NOT REPRESENTED BY COUNSEL.

1 At a stated term of the United States Court of Appeals for the Second Circuit, 2 held at the Thurgood Marshall United States Courthouse, 40 Foley Square, in the 3 City of New York, on the 14th day of February, two thousand twenty-three. 4 5 PRESENT: RAYMOND J. LOHIER, JR., 6 STEVEN J. MENASHI, 7 BETH ROBINSON, 8 Circuit Judges. 9 ------------------------------------------------------------------ 10 ERNESTINE WELCH, 11 12 Plaintiff-Appellant, 13 14 v. No. 21-1447-cv 15 16 BIO-REFERENCE LABORATORIES, INC., 17 18 Defendant-Appellee, 19 20 TERRY TUCKER, SUPERVISOR, JEAN

1 1 VOUGHT, SUPERVISOR, 2 3 Defendants. ∗ 4 ------------------------------------------------------------------ 5 FOR PLAINTIFF-APPELLANT: Ernestine Welch, pro se, 6 Hudson, NY 7 8 FOR DEFENDANT-APPELLEE: William R. Horwitz, Faegre 9 Drinker Biddle & Reath LLP, 10 New York, NY 11 12 Appeal from orders of the United States District Court for the Northern

13 District of New York (Brenda Kay Sannes, Judge).

14 Ernestine Welch, proceeding pro se, appeals from two post-judgment

15 orders of the United States District Court for the Northern District of New York

16 (Sannes, J.). The first order from which Welch appeals denied her motion to

17 vacate the judgment dismissing her case after she and defendant Bio-Reference

18 Laboratories, Inc. (“Bio-Reference”) entered a settlement agreement. The second

19 order from which she appeals denied her motion for reconsideration or

20 amendment of the judgment. We assume the parties’ familiarity with the

21 underlying facts and the record of prior proceedings, to which we refer only as

22 necessary to explain our decision to affirm.

∗ The Clerk of Court is directed to amend the caption as set forth above. 2 1 Welch sued Bio-Reference, her former employer, asserting that she had

2 been the victim of discrimination, retaliation, and a hostile work environment.

3 Welch (represented at the time by counsel) and Bio-Reference appeared at a

4 November 2020 settlement conference with the Magistrate Judge (Stewart, M.J.)

5 and agreed to settlement terms. The main points of the settlement were

6 summarized on the record. In exchange for dismissing the lawsuit, Welch would

7 (1) receive “a settlement payment in the gross amount of $18,000[,] less

8 withholding as W-2 wages,” (2) be responsible for “all taxes on the settlement

9 payment,” and (3) “indemnify Bio-Reference for any tax liability.” Supp. App’x

10 65. The Magistrate Court repeated its understanding of a “global settlement for

11 $18,000” and confirmed that Welch had discussed the pros and cons with her

12 attorney, understood it was a compromise, and was “in agreement” with the

13 outcome. Supp. App’x 70-72.

14 The written agreement stated that the $18,000 settlement would consist of

15 $14,000 sent to Welch, “less applicable withholding,” and $4,000 to her lawyer for

16 attorney’s fees. Supp. App’x 32. It also established a 21-day review period and

17 7-day post-signature revocation period, after which Bio-Reference would file a

18 fully executed stipulation of dismissal with prejudice in the District Court if

3 1 Welch had not revoked the agreement. The revocation process required Welch

2 to contact defense counsel before the 7 days expired. At Bio-Reference’s request,

3 Welch executed and sent to Bio-Reference a Form W-4 to facilitate the settlement

4 payment. Supp. App’x 25, 46.

5 On December 23, 2020, Welch signed the final settlement agreement,

6 which provided that the settlement would be subject to applicable tax

7 withholding but did not specify a withholding rate. Supp. App’x 32, 43. On

8 December 31, 2020, Bio-Reference sent the settlement check to Welch in the

9 amount of $8,502.20. The pay stub accompanying Welch’s check classified the

10 $14,000 payout as “SEVERANCE.” The assessed withholding was $3,080 in

11 federal taxes, $1,347 in New York taxes, and $1,060 in FICA taxes.

12 Welch was upset when she received the check because it was for

13 substantially less money than she expected. She wrote to the Magistrate Judge,

14 complaining that Bio-Reference had improperly characterized the settlement

15 payment as “wages[] subjected to tax withholdings,” when her understanding

16 was that “the defendants[ were] not required to withhold payroll taxes from the

17 award.” Dist. Ct. Dkt. No. 34, at 2. Welch’s letter was filed with the District

18 Court on January 4, 2021, but not docketed until January 12. Also on January

4 1 12—after the objection letter was filed but before it was docketed—the District

2 Court dismissed the case. Supp. App’x 21.

3 On February 16, 2021, at a hearing with the Magistrate Judge, Welch

4 clarified that her objection was to the classification of the payment as

5 “severance,” which she contended had placed it in a higher tax bracket. Supp.

6 App’x 53-54. The Magistrate Judge construed the letter as a motion to reopen the

7 case under Federal Rule of Civil Procedure 60(b) and recommended that the

8 District Court deny it “in light of the voluntary, clear, explicit and unqualified

9 settlement that was placed on the record.” Supp. App’x 78-80. By order dated

10 May 10, 2021, the District Court accepted the Report and Recommendation and

11 denied the motion. Supp. App’x 83-84. By order dated June 11, 2021, the District

12 Court denied a subsequent motion from Welch that it construed as requesting

13 reconsideration of its May 10, 2021 order. 1 The District Court held that Welch’s

1In view of Welch’s pro se status, the motion should have been construed as a motion to alter or amend the judgment under Rule 59(e), which may be filed up to 28 days after the entry of judgment. See Fed. R. Civ. P. 59(e); see also United States ex rel. McAllan v. City of New York, 248 F.3d 48, 52 (2d Cir. 2001).

5 1 second motion was both untimely (filed twenty-five days after the original order)

2 and without merit. Supp. App’x 85-89. Welch appealed both orders. 2

3 We need not decide what standard of review applies to Welch’s appeal,

4 because it fails even under de novo review, the standard most favorable to her.

5 A settlement agreement is a contract. See Omega Eng’g, Inc. v. Omega, S.A., 432

6 F.3d 437, 443 (2d Cir. 2005). Welch settled her case with the assistance of counsel

7 and, as she no longer disputes, was warned that tax would be withheld from the

8 settlement payment. The parties’ failure to specify the withholding rate is not a

9 reason to set aside their settlement agreement. To the extent that Welch claims

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bacon v. Phelps
961 F.3d 533 (Second Circuit, 2020)
United States ex rel. McAllan v. City of New York
248 F.3d 48 (Second Circuit, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
Welch v. Bio-Reference Laboratories, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/welch-v-bio-reference-laboratories-inc-ca2-2023.